These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20092599)

  • 1. Topical mitomycin C for the local treatment of a primary diffuse large B-cell lymphoma of the palpebral conjunctiva.
    Robinson L; McKellar M; Fitzharris B; Elder M
    Clin Exp Ophthalmol; 2009 Dec; 37(9):891-2. PubMed ID: 20092599
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
    Shields CL; Demirci H; Marr BP; Masheyekhi A; Materin M; Shields JA
    Arch Ophthalmol; 2005 Jan; 123(1):109-13. PubMed ID: 15642823
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma is amenable to local chemotherapy.
    Yu CS; Chiu SI; Ng CS; Chan HH; Tse RK
    Int Ophthalmol; 2008 Feb; 28(1):51-4. PubMed ID: 17589808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitomycin C in diffuse multilocal malignant conjunctival melanoma].
    Hoyer A; Raiskup F; Pillunat E
    Klin Monbl Augenheilkd; 2010 May; 227(5):430-2. PubMed ID: 20490999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C; Lommatzsch PK
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
    Yuen HK; Yeung EF; Chan NR; Chi SC; Lam DS
    Cornea; 2002 Nov; 21(8):838-9. PubMed ID: 12410049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical mitomycin C for the treatment of conjunctival tumor.
    Ozcan AA; Sizmaz S; Yagmur M
    Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival intraepithelial neoplasia.
    Snyder ME
    Ophthalmology; 2003 Jul; 110(7):1289. PubMed ID: 12867379
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK; Ertoy D; Kalayci D; Hasiripi H
    Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with mitomycin C eye drops for conjunctival diffuse intraepithelial neoplasia with sebaceous features.
    Rosner M; Hadar I; Rosen N
    Ophthalmic Plast Reconstr Surg; 2003 Nov; 19(6):477-9. PubMed ID: 14625495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
    Heigle TJ; Stulting RD; Palay DA
    Am J Ophthalmol; 1997 Sep; 124(3):397-9. PubMed ID: 9439368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant Ocular Surface Squamous Cell Papilloma Treated With Topical Mitomycin C.
    Parrozzani R; Frizziero L; Midena E
    JAMA Ophthalmol; 2017 Jul; 135(7):e170681. PubMed ID: 28715561
    [No Abstract]   [Full Text] [Related]  

  • 18. [Topical Mitomycin C as a therapy of conjunctival tumours].
    Schallenberg M; Niederdräing N; Steuhl KP; Meller D
    Ophthalmologe; 2008 Aug; 105(8):777-84. PubMed ID: 18618124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional mitomycin-C for the treatment of conjunctival Kaposi sarcoma.
    Korn BS; Park DJ; Kikkawa DO
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):e88-90. PubMed ID: 21178794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.